UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

Anticancer research, 2008-09, Vol.28 (5B), p.2851-2857

2008

Volltextzugriff (PDF)

Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses

The Journal of experimental medicine, 2000-01, Vol.191 (1), p.129-138

2000

Volltextzugriff (PDF)

Peptide dependency and selectivity of the NK cell inhibitory receptor Ly‐49C

European journal of immunology, 1999-09, Vol.29 (9), p.2748-2758

1999

Volltextzugriff (PDF)

T Cell Tolerance Based on Avidity Thresholds Rather Than Complete Deletion Allows Maintenance of Maximal Repertoire Diversity

The Journal of immunology (1950), 2000-07, Vol.165 (1), p.25-33

2000

Volltextzugriff (PDF)

Recognition of β2-Microglobulin-Negative (β2m-) T-Cell Blasts by Natural Killer Cells from Normal but not from β2m-Mice: Nonresponsiveness Controlled by β2m-Bone Marrow in Chimeric Mice

Proceedings of the National Academy of Sciences - PNAS, 1991-11, Vol.88 (22), p.10332-10336

1991

Volltextzugriff (PDF)

Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in Sweden: comparative analysis of drug utilization, costs, and hematologic response

Advances in therapy, 2005-05, Vol.22 (3), p.208-224

2005

Volltextzugriff (PDF)

IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression

The Journal of immunology (1950), 1995-06, Vol.154 (12), p.6291-6298

1995

Volltextzugriff (PDF)

Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in sweden: comparative analysis of drug utilization, costs, and hematologic response

Advances in therapy, 2005, Vol.22 (3), p.24

2005

Volltextzugriff (PDF)

Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene

The Journal of experimental medicine, 1993, Vol.177 (1), p.201-205

1993

Volltextzugriff (PDF)

Major Histocompatibility Complex Class I-Specific and -Restricted Killing of β2-Microglobulin-Deficient Cells by CD8+Cytotoxic T Lymphocytes

Proceedings of the National Academy of Sciences - PNAS, 1992-12, Vol.89 (23), p.11381-11385

1992

Volltextzugriff (PDF)

Specific vaccination based on the Her2/neu proto-oncogene

European journal of cancer (1990), 2001-09, Vol.37, p.S19-S19

2001

Volltextzugriff (PDF)

Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides

International immunology, 1995-06, Vol.7 (6), p.919-928

1995

Volltextzugriff (PDF)

Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells

European journal of immunology, 1993-10, Vol.23 (10), p.2606-2613

1993

Volltextzugriff (PDF)

Natural killer clones recognize specific soluble HLA class I molecules

European journal of immunology, 1996-03, Vol.26 (3), p.683-689

1996

Volltextzugriff (PDF)

Recruitment and Activation of Natural Killer (Nk) Cells in Vivo Determined by the Target Cell Phenotype

The Journal of experimental medicine, 2000-01, Vol.191 (1), p.129-138

2000

Volltextzugriff (PDF)

Assessment of major histocompatibility complex class I interaction with Epstein‐Barr virus and human immunodeficiency virus peptides by elevation of membrane H‐2 and HLA in peptide loading‐deficient cells

European journal of immunology, 1992-10, Vol.22 (10), p.2697-2703

1992

Volltextzugriff (PDF)

Different types of allospecific CTL clones identified by their ability to recognize peptide loading‐defective target cells

European journal of immunology, 1991-11, Vol.21 (11), p.2767-2774

1991

Volltextzugriff (PDF)

Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with β2‐microglobulin

European journal of immunology, 1993-08, Vol.23 (8), p.1752-1756

1993

Volltextzugriff (PDF)

β2 ‐Microglobulin‐deficient NK cells show increased sensitivity to MHC class I‐mediated inhibition, but self tolerance does not depend upon target cell expression of H‐2Kb and Db heavy chains

European journal of immunology, 1998-01, Vol.28 (1), p.370-378

1998

Volltextzugriff (PDF)

Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with beta 2-microglobulin

European journal of immunology, 1993-08, Vol.23 (8), p.1752-1756

1993

Volltextzugriff (PDF)

Identification of H‐2K b ‐, D b ‐ and D d ‐binding peptides derived from amino acid sequences of polyoma virus T antigens

International journal of cancer, 1993-07, Vol.54 (6), p.992-995

1993

Volltextzugriff (PDF)

Superdominance Among Immunodominant H-2Kb-Restricted Epitopes and Reversal by Dendritic Cell-Mediated Antigen Delivery

The Journal of immunology (1950), 1998-04, Vol.160 (7), p.3163-3169

1998

Volltextzugriff (PDF)

Major histocompatibility complex class I-specific and -restricted killing of (beta)(2)-microglobulin-deficient cells by CD8(plus) cytotoxic T lymphocytes

Proceedings of the National Academy of Sciences - PNAS, 1992-12, Vol.89 (23), p.11381

1992

Volltextzugriff (PDF)

The RMA‐S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejection

International journal of cancer, 1991, Vol.47 (S6), p.38-44

1991

Volltextzugriff (PDF)

Identification of H‐2Kb‐, Db‐ and Dd‐binding peptides derived from amino acid sequences of polyoma virus T antigens

International journal of cancer, 1993-07, Vol.54 (6), p.992-995

1993

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Mice
(13)
Animals
(12)
Immunology
(10)
Mice, Inbred C57bl
(10)
Humans
(9)
Medicin Och Hälsovetenskap
(9)
Biological And Medical Sciences
(8)
Killer Cells, Natural - Immunology
(7)
T-Lymphocytes, Cytotoxic - Immunology
(7)
Mutation
(6)
Cytotoxicity, Immunologic
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Fundamental Immunology
(5)
Tumors
(5)
H-2 Antigens - Immunology
(4)
H-2 Antigens - Metabolism
(4)
Male
(4)
Middle Aged
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses

Peptide dependency and selectivity of the NK cell inhibitory receptor Ly‐49C

T Cell Tolerance Based on Avidity Thresholds Rather Than Complete Deletion Allows Maintenance of Maximal Repertoire Diversity

Recognition of β2-Microglobulin-Negative (β2m-) T-Cell Blasts by Natural Killer Cells from Normal but not from β2m-Mice: Nonresponsiveness Controlled by β2m-Bone Marrow in Chimeric Mice

Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in Sweden: comparative analysis of drug utilization, costs, and hematologic response

IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression

Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in sweden: comparative analysis of drug utilization, costs, and hematologic response

Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene

Major Histocompatibility Complex Class I-Specific and -Restricted Killing of β2-Microglobulin-Deficient Cells by CD8+Cytotoxic T Lymphocytes

Specific vaccination based on the Her2/neu proto-oncogene

Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides

Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells

Natural killer clones recognize specific soluble HLA class I molecules

Recruitment and Activation of Natural Killer (Nk) Cells in Vivo Determined by the Target Cell Phenotype

Assessment of major histocompatibility complex class I interaction with Epstein‐Barr virus and human immunodeficiency virus peptides by elevation of membrane H‐2 and HLA in peptide loading‐deficient cells

Different types of allospecific CTL clones identified by their ability to recognize peptide loading‐defective target cells

Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with β2‐microglobulin

β2 ‐Microglobulin‐deficient NK cells show increased sensitivity to MHC class I‐mediated inhibition, but self tolerance does not depend upon target cell expression of H‐2Kb and Db heavy chains

Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with beta 2-microglobulin

Identification of H‐2K b ‐, D b ‐ and D d ‐binding peptides derived from amino acid sequences of polyoma virus T antigens

Superdominance Among Immunodominant H-2Kb-Restricted Epitopes and Reversal by Dendritic Cell-Mediated Antigen Delivery

Major histocompatibility complex class I-specific and -restricted killing of (beta)(2)-microglobulin-deficient cells by CD8(plus) cytotoxic T lymphocytes

The RMA‐S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejection

Identification of H‐2Kb‐, Db‐ and Dd‐binding peptides derived from amino acid sequences of polyoma virus T antigens

Suchergebnisse filtern